Archived NHGRI record
2020 State Bills Louisiana 2020 SB 204
Louisiana
- Status
- Enacted
- Database
- NHGRI archive
- Source database updated
- February 8, 2024
- Snapshot retrieved
- September 1, 2026
Summary
Requires coverage of cancer treatment targeting a specific genetic mutation. Prohibits a health coverage plan from denying coverage for the treatment of a metastatic or unresectable tumor with a medically necessary drug on the sole basis that the drug is not indicated for the location in the body of the patient's cancer, if the drug is FDA approved for the treatment of the specific mutation of the patient's cancer. 6/11/2020 Signed by the Governor. Becomes Act No. 222. Effective 1/1/2021.
Record details
Archived source metadata
Source links
Archive details
Courtesy: National Human Genome Research Institute. This archive preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.
Report a source problem
Report a transcription problem, changed legal status, or newer official source for human review. Any correction remains separate from the archived NHGRI wording.
Cite this archived record
NHGRI Genome Statute and Legislation Database. 2020 State Bills Louisiana 2020 SB 204. Archived by Who Owns Your DNA? Retrieved September 1, 2026. https://whoownsyourdna.org/source-records/nhgri/nhgri-fb267b9730bb4510a956/